Home / Market News / $SGP

$SGP news and market catalysts

The 1 most recent market catalysts affecting $SGP, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

1 catalysts 0 high impact 0 bullish 0 bearish Biotechnology
Aug 14, 2026 Corporate Catalyst Neutral Impact 65
Raymond James Initiates Coverage On SpyGlass Pharma with Outperform Rating, Announces Price Target of $39
Raymond James analyst Christopher Raymond has initiated coverage on SpyGlass Pharma (SGP) with an 'Outperform' rating and a $39 price target. This event is significant as it marks …
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.